DHL Supply Chain Launches New Logistics Solution For U.S. Health Systems

By Amit Chowdhry ● Today at 1:05 PM

DHL Supply Chain has launched a new logistics solution for U.S. health systems designed to centralize inventory and medical support activities while connecting supplies, drugs, and equipment to hospitals and other points of care through dedicated transportation and final-mile delivery.

The offering is designed for increasingly complex healthcare networks that can include hospitals, physician groups, outpatient facilities, and other care locations. DHL said the model combines inventory management and medical support operations within a consolidated service center, creating a centralized hub for storing, preparing, managing, and distributing products throughout a healthcare system.

The launch comes as health systems face growing logistical pressures from expanding patient volumes, supply and drug shortages, rising costs, and increasingly distributed care networks.

DHL cited data showing that U.S. inpatient volume increased 5.3% in 2025 while outpatient volume rose 9.8%. During the same period, total hospital expenses rose 7.5%, with supply costs up 9.9% and drug expenses up 13.6%.

DHL’s solution is intended to help health systems replace fragmented supply chain operations with a more coordinated model that provides greater visibility across their networks.

At the center of the offering is a customizable consolidated service center that can handle product storage, preparation, inventory management, and distribution. Moving these activities into a centralized operation can also free space within hospitals and outpatient facilities that might otherwise be used for storing supplies.

DHL’s warehouse management system tracks inventory and product movement across the healthcare network, giving administrators a broader view of product availability and distribution.

Data and predictive analytics can support inventory positioning, replenishment, purchasing decisions, and continuous operational improvement. DHL said the systemwide approach may also help organizations reduce product variation, standardize purchasing, and make greater use of the purchasing scale available across consolidated healthcare networks.

Health systems can incorporate artificial intelligence, robotics, and other automation technologies within the consolidated service center to increase speed, accuracy, and labor efficiency.

The model is designed to address a common challenge for large health systems where inventory, medical preparation, and transportation may be managed across multiple facilities, suppliers, and logistics providers.

DHL said fragmentation can lead to limited inventory visibility, duplicate orders, less favorable purchasing decisions, shortages, and emergency purchases.

Centralized visibility is becoming more important as hospitals and physician practices consolidate into larger healthcare organizations. The ability to combine data from multiple care locations with logistics technology can give healthcare leaders a clearer picture of where products are located and where they will be needed.

Dedicated transportation connects the centralized service center with individual care locations.

DHL fleets can transport consolidated shipments, bulk supplies, and large medical equipment to hospital receiving docks and other healthcare facilities. The company’s healthcare delivery service can also provide scheduled and urgent final-mile deliveries directly to points of care.

The new offering expands DHL’s healthcare logistics capabilities beyond traditional distribution operations and moves the company closer to clinical environments where product availability can directly affect healthcare operations.

The launch is also part of DHL Group’s broader Strategy 2030 plan, which identifies life sciences and healthcare as a strategic growth market.

DHL Group has set a goal of increasing overall revenue by 50% by 2030 and has committed €2 billion through 2030 to expand its DHL Health Logistics capabilities globally. Half of that investment is allocated to the Americas.

The company has also completed construction of its East Coast Center of Excellence in Annville, Pennsylvania. The approximately one-million-square-foot facility is focused on life sciences and healthcare distribution.

DHL has additionally expanded its healthcare logistics operations through the acquisition of CRYOPDP, a specialty courier serving clinical trials, biopharmaceutical companies, and cell and gene therapy programs.

The health systems offering extends those capabilities across a broader portion of the healthcare supply chain, creating an operating model that combines centralized inventory management, technology, dedicated transportation, and final-mile delivery.

DHL said the solution is intended to improve inventory visibility, simplify logistics operations, strengthen product availability, and coordinate the movement of critical drugs, supplies, and equipment across expanding healthcare networks.

KEY QUOTES:

“The supply chain is an essential part of patient care, yet many health systems manage inventory, preparation, and transportation across disconnected locations, networks, and providers. That fragmentation can create blind spots that contribute to shortages, duplicate orders, less favorable purchasing decisions, and costly emergency purchases.”

Jim Saponaro, President, Life Sciences And Healthcare At DHL Supply Chain North America

“As hospitals and physician practices become part of larger healthcare networks, visibility across the supply chain becomes increasingly critical. The ability to combine systemwide data with the right technologies gives them a stronger foundation for making decisions, capturing economies of scale and adapting operations as their networks evolve.”

Jim Saponaro, President, Life Sciences And Healthcare At DHL Supply Chain North America

“Health systems are an important next step as we expand the support we provide across the healthcare ecosystem. This move brings our healthcare logistics expertise closer to the point of care, where reliable product availability directly supports clinicians and patients.”

Jim Saponaro, President, Life Sciences And Healthcare At DHL Supply Chain North America

Exit mobile version